Azitromicina: desenvolvimento e validação de métodos de análise em formas farmacêuticas

Detalhes bibliográficos
Autor(a) principal: Ferreira, João Ronaldo Notargiacomo
Data de Publicação: 2007
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Manancial - Repositório Digital da UFSM
Texto Completo: http://repositorio.ufsm.br/handle/1/6030
Resumo: Azithromycin (AZ) is a macrolide antibiotic derivate from erytromycin. AZ has a broad spectrum of activity against common gram-negative pathogens and has been used for the treatment of respiratory tract infection, skin infections and sexually transmitted diseases. In the Brazilian market AZ is available as tablets, compounded capsules and powder for oral suspension. The official methods for the assay of AZ in bulk form; capsules and powder for oral suspension are high performance liquid chromatography or microbiological diffusion assay. No monographs are reported in the pharmacopoeias for AZ evaluation in tablets. In this work two spectrophotometric methods were developed and validated for AZ analysis in tablets and powder for oral suspension. The first method was based on the reaction of AZ with concentrated sulfuric acid (98 % w/v), with detection at 226 nm. The other method was based in the charge-transfer reaction of the drug with s-acceptor iodine, with detection at 363 nm. Both methods showed good linearity (r>0.99), precision (CV<5%) and accuracy (>99%). The results obtained with the proposed methods were in good agreement with those obtained by microbiological diffusion agar method. The optimization of dissolution test conditions for in vitro quality control of AZ in tablets was also studied. The use of 900 mL of 0.1N HCl at 37.0 ± 0.5 ºC, paddle as apparatus, at a stirring rate of 50 rpm, provided satisfactory results for tested products. The percent dissolution of AZ in the established condition was more than 90% in 45 minutes. The validated spectrophotometric method used to evaluate the dissolution testing showed to be specific (with no interference of the placebo or tablets in the quantification of AZ), linear (r>0.99), precise (RSD<5%) and accurate (>97%). The drug showed satisfactory stability in the selected dissolution medium
id UFSM_5758c3ff4741c3a8f149243180c9876f
oai_identifier_str oai:repositorio.ufsm.br:1/6030
network_acronym_str UFSM
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str
spelling Azitromicina: desenvolvimento e validação de métodos de análise em formas farmacêuticasAzithromycin: development and validation of analysis methods in pharmaceutical dosage formsAzitromicinaEspectrofotometriaValidaçãoDissoluçãoAzithromycinSpectrophotometryValidationDissolutionCNPQ::CIENCIAS DA SAUDE::FARMACIAAzithromycin (AZ) is a macrolide antibiotic derivate from erytromycin. AZ has a broad spectrum of activity against common gram-negative pathogens and has been used for the treatment of respiratory tract infection, skin infections and sexually transmitted diseases. In the Brazilian market AZ is available as tablets, compounded capsules and powder for oral suspension. The official methods for the assay of AZ in bulk form; capsules and powder for oral suspension are high performance liquid chromatography or microbiological diffusion assay. No monographs are reported in the pharmacopoeias for AZ evaluation in tablets. In this work two spectrophotometric methods were developed and validated for AZ analysis in tablets and powder for oral suspension. The first method was based on the reaction of AZ with concentrated sulfuric acid (98 % w/v), with detection at 226 nm. The other method was based in the charge-transfer reaction of the drug with s-acceptor iodine, with detection at 363 nm. Both methods showed good linearity (r>0.99), precision (CV<5%) and accuracy (>99%). The results obtained with the proposed methods were in good agreement with those obtained by microbiological diffusion agar method. The optimization of dissolution test conditions for in vitro quality control of AZ in tablets was also studied. The use of 900 mL of 0.1N HCl at 37.0 ± 0.5 ºC, paddle as apparatus, at a stirring rate of 50 rpm, provided satisfactory results for tested products. The percent dissolution of AZ in the established condition was more than 90% in 45 minutes. The validated spectrophotometric method used to evaluate the dissolution testing showed to be specific (with no interference of the placebo or tablets in the quantification of AZ), linear (r>0.99), precise (RSD<5%) and accurate (>97%). The drug showed satisfactory stability in the selected dissolution mediumAzitromicina (AZ) é um antibiótico macrolídeo derivado da eritromicina. AZ apresenta um grande espectro de atividade contra patógenos Gram negativos comuns e tem sido utilizada para o tratamento de infecções do trato respiratório, infecções da pele e doenças sexualmente transmissíveis. No mercado brasileiro a AZ está disponível na forma de comprimidos, cápsulas manipuladas e pó para suspensão oral. Os métodos oficiais para o doseamento de AZ como matéria-prima; cápsulas e pó para a suspensão oral são a cromatografia líquida de alta eficiência ou o método microbiológico de difusão em ágar. Não existem monografias em farmacopéias para avaliação de AZ em comprimidos. Neste trabalho dois métodos espectrofotométricos foram desenvolvidos e validados para a análise de AZ em comprimidos e em pó para suspensão oral. O primeiro método foi baseado na reação de AZ com ácido sulfúrico concentrado (98%, p/v), com detecção em 226 nm. O outro método foi baseado na reação de complexo de transferência de carga do fármaco com o s-aceptor iodo, com detecção em 363 nm. Ambos os métodos mostraram linearidade (r>0,99), precisão (CV<5%) e exatidão (>99%). Os resultados obtidos com os métodos propostos estavam de acordo com aqueles obtidos com o método microbiológico de difusão em ágar. A otimização das condições do teste de dissolução para o controle de qualidade in vitro de AZ em comprimidos foi também estudado. O uso de 900 mL de HCl 0,1N, a 37 ºC ± 0,5 ºC, aparato pá, a um a velocidade de 50 rpm, demonstrou resultados satisfatórios para produtos testados. A percentagem de dissolução de AZ na condição estabelecida foi superior a 90% em 45 minutos. O método espectrofotométrico validado para avaliar a dissolução mostrou-se específico, sem interferência do placebo dos comprimidos, na quantificação de AZ, linear (r>0.99), preciso (CV< 5%) e exato (>97%). O fármaco mostrou estabilidade satisfatória no meio de dissolução selecionadoUniversidade Federal de Santa MariaBRFarmáciaUFSMPrograma de Pós-Graduação em Ciências FarmacêuticasCardoso, Simone Gonçalveshttp://lattes.cnpq.br/0137281979458686Silva, Marcos Antonio Segattohttp://lattes.cnpq.br/3411646377586063Silva, Elisabete de Avila dahttp://lattes.cnpq.br/0077152291293677Ferreira, João Ronaldo Notargiacomo2007-07-032007-07-032007-05-04info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfapplication/pdfFERREIRA, João Ronaldo Notargiacomo. Azithromycin: development and validation of analysis methods in pharmaceutical dosage forms. 2007. 99 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2007.http://repositorio.ufsm.br/handle/1/6030porinfo:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2023-01-06T16:48:40Zoai:repositorio.ufsm.br:1/6030Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2023-01-06T16:48:40Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Azitromicina: desenvolvimento e validação de métodos de análise em formas farmacêuticas
Azithromycin: development and validation of analysis methods in pharmaceutical dosage forms
title Azitromicina: desenvolvimento e validação de métodos de análise em formas farmacêuticas
spellingShingle Azitromicina: desenvolvimento e validação de métodos de análise em formas farmacêuticas
Ferreira, João Ronaldo Notargiacomo
Azitromicina
Espectrofotometria
Validação
Dissolução
Azithromycin
Spectrophotometry
Validation
Dissolution
CNPQ::CIENCIAS DA SAUDE::FARMACIA
title_short Azitromicina: desenvolvimento e validação de métodos de análise em formas farmacêuticas
title_full Azitromicina: desenvolvimento e validação de métodos de análise em formas farmacêuticas
title_fullStr Azitromicina: desenvolvimento e validação de métodos de análise em formas farmacêuticas
title_full_unstemmed Azitromicina: desenvolvimento e validação de métodos de análise em formas farmacêuticas
title_sort Azitromicina: desenvolvimento e validação de métodos de análise em formas farmacêuticas
author Ferreira, João Ronaldo Notargiacomo
author_facet Ferreira, João Ronaldo Notargiacomo
author_role author
dc.contributor.none.fl_str_mv Cardoso, Simone Gonçalves
http://lattes.cnpq.br/0137281979458686
Silva, Marcos Antonio Segatto
http://lattes.cnpq.br/3411646377586063
Silva, Elisabete de Avila da
http://lattes.cnpq.br/0077152291293677
dc.contributor.author.fl_str_mv Ferreira, João Ronaldo Notargiacomo
dc.subject.por.fl_str_mv Azitromicina
Espectrofotometria
Validação
Dissolução
Azithromycin
Spectrophotometry
Validation
Dissolution
CNPQ::CIENCIAS DA SAUDE::FARMACIA
topic Azitromicina
Espectrofotometria
Validação
Dissolução
Azithromycin
Spectrophotometry
Validation
Dissolution
CNPQ::CIENCIAS DA SAUDE::FARMACIA
description Azithromycin (AZ) is a macrolide antibiotic derivate from erytromycin. AZ has a broad spectrum of activity against common gram-negative pathogens and has been used for the treatment of respiratory tract infection, skin infections and sexually transmitted diseases. In the Brazilian market AZ is available as tablets, compounded capsules and powder for oral suspension. The official methods for the assay of AZ in bulk form; capsules and powder for oral suspension are high performance liquid chromatography or microbiological diffusion assay. No monographs are reported in the pharmacopoeias for AZ evaluation in tablets. In this work two spectrophotometric methods were developed and validated for AZ analysis in tablets and powder for oral suspension. The first method was based on the reaction of AZ with concentrated sulfuric acid (98 % w/v), with detection at 226 nm. The other method was based in the charge-transfer reaction of the drug with s-acceptor iodine, with detection at 363 nm. Both methods showed good linearity (r>0.99), precision (CV<5%) and accuracy (>99%). The results obtained with the proposed methods were in good agreement with those obtained by microbiological diffusion agar method. The optimization of dissolution test conditions for in vitro quality control of AZ in tablets was also studied. The use of 900 mL of 0.1N HCl at 37.0 ± 0.5 ºC, paddle as apparatus, at a stirring rate of 50 rpm, provided satisfactory results for tested products. The percent dissolution of AZ in the established condition was more than 90% in 45 minutes. The validated spectrophotometric method used to evaluate the dissolution testing showed to be specific (with no interference of the placebo or tablets in the quantification of AZ), linear (r>0.99), precise (RSD<5%) and accurate (>97%). The drug showed satisfactory stability in the selected dissolution medium
publishDate 2007
dc.date.none.fl_str_mv 2007-07-03
2007-07-03
2007-05-04
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv FERREIRA, João Ronaldo Notargiacomo. Azithromycin: development and validation of analysis methods in pharmaceutical dosage forms. 2007. 99 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2007.
http://repositorio.ufsm.br/handle/1/6030
identifier_str_mv FERREIRA, João Ronaldo Notargiacomo. Azithromycin: development and validation of analysis methods in pharmaceutical dosage forms. 2007. 99 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2007.
url http://repositorio.ufsm.br/handle/1/6030
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
BR
Farmácia
UFSM
Programa de Pós-Graduação em Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade Federal de Santa Maria
BR
Farmácia
UFSM
Programa de Pós-Graduação em Ciências Farmacêuticas
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1805922043175108608